Clinical Trial Update: Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and efficacy of empagliflozin in patients with diabetes mellitus undergoing planned percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Research Institute for Complex Problems of Cardiovascular Diseases, Russia | Conditions: Coronary Artery Disease, Diabetes Mellitus | Phase 4 | Status: COMPLETED